FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W95909858> ?p ?o ?g. }

• W95909858 endingPage "539.e1" @default.
• W95909858 startingPage "533" @default.
• W95909858 abstract "Purpose To describe the association of demographic, behavioral, medical, and nonretinal ocular factors with the incidence of neovascular age-related macular degeneration (AMD) and central geographic atrophy (CGA) in the Age-Related Eye Disease Study (AREDS), a randomized trial of antioxidants and zinc supplementation prophylaxis for development of advanced AMD. Design Clinic-based prospective cohort study. Participants Of individuals with early or intermediate AMD at baseline with a median follow-up of 6.3 years, 788 were at risk of developing advanced AMD in one eye (the fellow eye had advanced AMD), and 2506 were at risk in both eyes. Methods The incidence of neovascular AMD and CGA was assessed from stereoscopic color fundus photographs taken at baseline and at annual visits beginning at year 2. Main Outcome Measures Neovascular AMD was defined as photocoagulation for choroidal neovascularization, or photographic documentation at the reading center of any of the following: nondrusenoid retinal pigment epithelial detachment, serous or hemorrhagic retinal detachment, hemorrhage under the retina or the retinal pigment epithelium, and subretinal fibrosis. Central geographic atrophy was defined as geographic atrophy involving the center of the macula. Results In multivariable models, in persons at risk of advanced AMD in both eyes, while controlling for age, gender, and AREDS treatment group, the following variables were statistically significantly associated with the incidence of neovascular AMD: race (odds ratio [OR], white vs. black, 6.77; 95% confidence interval [CI], 1.24–36.9) and larger amount smoked (OR, >10 vs. ≤10 pack-years [a pack-year is an average of 1 pack of cigarette smoked per day for a year], 1.55; 95% CI, 1.15–2.09). The following were statistically significantly associated with the incidence of CGA: less education (OR, high school graduate or less vs. college graduate, 1.75; 95% CI, 1.10–2.78), greater body mass index (BMI) (OR, obese vs. nonobese, 1.93; 95% CI, 1.25–2.65), larger amount smoked (OR, >10 pack-years vs. ≤10 pack-years, 1.82; 95% CI, 1.25–2.65), and antacid use (OR, 0.29; 95% CI, 0.09–0.91). In persons at risk of developing advanced AMD in one eye, the incidence of neovascular AMD was associated with diabetes (OR, 1.88; 95% CI, 1.07–3.31), and the incidence of CGA was associated with use of antiinflammatory medications (OR, 0.22; 95% CI, 0.08–0.59). Conclusions Results suggest that, among persons with early or intermediate AMD, smoking and BMI are modifiable factors associated with progression to advanced AMD, and suggest other associations (e.g., use of antacids and antiinflammatory medications) that warrant further study. This article contains additional online-only material available at http://www.ophsource.org/periodicals/ophtha. To describe the association of demographic, behavioral, medical, and nonretinal ocular factors with the incidence of neovascular age-related macular degeneration (AMD) and central geographic atrophy (CGA) in the Age-Related Eye Disease Study (AREDS), a randomized trial of antioxidants and zinc supplementation prophylaxis for development of advanced AMD. Clinic-based prospective cohort study. Of individuals with early or intermediate AMD at baseline with a median follow-up of 6.3 years, 788 were at risk of developing advanced AMD in one eye (the fellow eye had advanced AMD), and 2506 were at risk in both eyes. The incidence of neovascular AMD and CGA was assessed from stereoscopic color fundus photographs taken at baseline and at annual visits beginning at year 2. Neovascular AMD was defined as photocoagulation for choroidal neovascularization, or photographic documentation at the reading center of any of the following: nondrusenoid retinal pigment epithelial detachment, serous or hemorrhagic retinal detachment, hemorrhage under the retina or the retinal pigment epithelium, and subretinal fibrosis. Central geographic atrophy was defined as geographic atrophy involving the center of the macula. In multivariable models, in persons at risk of advanced AMD in both eyes, while controlling for age, gender, and AREDS treatment group, the following variables were statistically significantly associated with the incidence of neovascular AMD: race (odds ratio [OR], white vs. black, 6.77; 95% confidence interval [CI], 1.24–36.9) and larger amount smoked (OR, >10 vs. ≤10 pack-years [a pack-year is an average of 1 pack of cigarette smoked per day for a year], 1.55; 95% CI, 1.15–2.09). The following were statistically significantly associated with the incidence of CGA: less education (OR, high school graduate or less vs. college graduate, 1.75; 95% CI, 1.10–2.78), greater body mass index (BMI) (OR, obese vs. nonobese, 1.93; 95% CI, 1.25–2.65), larger amount smoked (OR, >10 pack-years vs. ≤10 pack-years, 1.82; 95% CI, 1.25–2.65), and antacid use (OR, 0.29; 95% CI, 0.09–0.91). In persons at risk of developing advanced AMD in one eye, the incidence of neovascular AMD was associated with diabetes (OR, 1.88; 95% CI, 1.07–3.31), and the incidence of CGA was associated with use of antiinflammatory medications (OR, 0.22; 95% CI, 0.08–0.59). Results suggest that, among persons with early or intermediate AMD, smoking and BMI are modifiable factors associated with progression to advanced AMD, and suggest other associations (e.g., use of antacids and antiinflammatory medications) that warrant further study." @default.
• W95909858 created "2016-06-24" @default.
• W95909858 date "2005-04-01" @default.
• W95909858 modified "2023-10-05" @default.
• W95909858 title "Risk Factors for the Incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS)AREDS report no. 19" @default.
• W95909858 cites W109974915 @default.
• W95909858 cites W1487528435 @default.
• W95909858 cites W1495502816 @default.
• W95909858 cites W1499978209 @default.
• W95909858 cites W1507919748 @default.
• W95909858 cites W1543801259 @default.
• W95909858 cites W1548644132 @default.
• W95909858 cites W1565600091 @default.
• W95909858 cites W1740303948 @default.
• W95909858 cites W1919546919 @default.
• W95909858 cites W1970385641 @default.
• W95909858 cites W1996970455 @default.
• W95909858 cites W1999316239 @default.
• W95909858 cites W2000399151 @default.
• W95909858 cites W2021311336 @default.
• W95909858 cites W2036755683 @default.
• W95909858 cites W2044425793 @default.
• W95909858 cites W2045684086 @default.
• W95909858 cites W2049846787 @default.
• W95909858 cites W20523022 @default.
• W95909858 cites W2058381006 @default.
• W95909858 cites W2060346414 @default.
• W95909858 cites W2064037258 @default.
• W95909858 cites W2066326071 @default.
• W95909858 cites W2090607081 @default.
• W95909858 cites W2093802575 @default.
• W95909858 cites W2099496254 @default.
• W95909858 cites W2099756978 @default.
• W95909858 cites W2104421727 @default.
• W95909858 cites W2116163760 @default.
• W95909858 cites W2117127611 @default.
• W95909858 cites W2120590773 @default.
• W95909858 cites W2144839999 @default.
• W95909858 cites W2147440920 @default.
• W95909858 cites W2153590450 @default.
• W95909858 cites W2169908614 @default.
• W95909858 cites W2408961477 @default.
• W95909858 cites W2561069604 @default.
• W95909858 cites W2566154985 @default.
• W95909858 cites W2598520882 @default.
• W95909858 cites W3172478362 @default.
• W95909858 cites W35378611 @default.
• W95909858 cites W2033902287 @default.
• W95909858 doi "https://doi.org/10.1016/j.ophtha.2004.10.047" @default.
• W95909858 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1513667" @default.
• W95909858 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15808240" @default.
• W95909858 hasPublicationYear "2005" @default.
• W95909858 type Work @default.
• W95909858 sameAs 95909858 @default.
• W95909858 citedByCount "593" @default.
• W95909858 countsByYear W959098582012 @default.
• W95909858 countsByYear W959098582013 @default.
• W95909858 countsByYear W959098582014 @default.
• W95909858 countsByYear W959098582015 @default.
• W95909858 countsByYear W959098582016 @default.
• W95909858 countsByYear W959098582017 @default.
• W95909858 countsByYear W959098582018 @default.
• W95909858 countsByYear W959098582019 @default.
• W95909858 countsByYear W959098582020 @default.
• W95909858 countsByYear W959098582021 @default.
• W95909858 countsByYear W959098582022 @default.
• W95909858 countsByYear W959098582023 @default.
• W95909858 crossrefType "journal-article" @default.
• W95909858 hasBestOaLocation W959098582 @default.
• W95909858 hasConcept C118487528 @default.
• W95909858 hasConcept C120665830 @default.
• W95909858 hasConcept C121332964 @default.
• W95909858 hasConcept C126322002 @default.
• W95909858 hasConcept C141071460 @default.
• W95909858 hasConcept C156957248 @default.
• W95909858 hasConcept C188816634 @default.
• W95909858 hasConcept C2776403814 @default.
• W95909858 hasConcept C2779093074 @default.
• W95909858 hasConcept C2781359195 @default.
• W95909858 hasConcept C50440223 @default.
• W95909858 hasConcept C61511704 @default.
• W95909858 hasConcept C71924100 @default.
• W95909858 hasConceptScore W95909858C118487528 @default.
• W95909858 hasConceptScore W95909858C120665830 @default.
• W95909858 hasConceptScore W95909858C121332964 @default.
• W95909858 hasConceptScore W95909858C126322002 @default.
• W95909858 hasConceptScore W95909858C141071460 @default.
• W95909858 hasConceptScore W95909858C156957248 @default.
• W95909858 hasConceptScore W95909858C188816634 @default.
• W95909858 hasConceptScore W95909858C2776403814 @default.
• W95909858 hasConceptScore W95909858C2779093074 @default.
• W95909858 hasConceptScore W95909858C2781359195 @default.
• W95909858 hasConceptScore W95909858C50440223 @default.
• W95909858 hasConceptScore W95909858C61511704 @default.
• W95909858 hasConceptScore W95909858C71924100 @default.
• W95909858 hasIssue "4" @default.
• W95909858 hasLocation W959098581 @default.
• W95909858 hasLocation W959098582 @default.

• next